-
2
-
-
0036524058
-
Influenza virus infection in adult solid organ transplant recipients
-
Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2:287.
-
(2002)
Am J Transplant
, vol.2
, pp. 287
-
-
Vilchez, R.A.1
McCurry, K.2
Dauber, J.3
-
3
-
-
67649216525
-
Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak
-
Ginocchio CC, Zhang F, Manji R, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009; 45:191.
-
(2009)
J Clin Virol
, vol.45
, pp. 191
-
-
Ginocchio, C.C.1
Zhang, F.2
Manji, R.3
-
4
-
-
68849091225
-
Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients
-
Kuypers J, Campbell AP, Cent A, et al. Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl Infect Dis 2009; 11:298.
-
(2009)
Transpl Infect Dis
, vol.11
, pp. 298
-
-
Kuypers, J.1
Campbell, A.P.2
Cent, A.3
-
5
-
-
3042556185
-
Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1,2,3, and 4
-
Templeton KE, Scheltinga SA, Beersma MF, et al. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 2004; 42:1564.
-
(2004)
J Clin Microbiol
, vol.42
, pp. 1564
-
-
Templeton, K.E.1
Scheltinga, S.A.2
Beersma, M.F.3
-
6
-
-
33746366176
-
Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children
-
Kuypers J, Wright N, Ferrenberg J, et al. Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol 2006; 44:2382.
-
(2006)
J Clin Microbiol
, vol.44
, pp. 2382
-
-
Kuypers, J.1
Wright, N.2
Ferrenberg, J.3
-
7
-
-
33749570155
-
Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness
-
Freymuth F, Vabret A, Cuvillon-Nimal D, et al. Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. J Med Virol 2006; 78:1498.
-
(2006)
J Med Virol
, vol.78
, pp. 1498
-
-
Freymuth, F.1
Vabret, A.2
Cuvillon-Nimal, D.3
-
8
-
-
1442300734
-
Superiority of reversetranscription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children
-
Weinberg GA, Erdman DD, Edwards KM, et al. Superiority of reversetranscription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis 2004; 189:706.
-
(2004)
J Infect Dis
, vol.189
, pp. 706
-
-
Weinberg, G.A.1
Erdman, D.D.2
Edwards, K.M.3
-
9
-
-
0028830829
-
Parainfluenza and influenza virus infections in pediatric organ transplant recipients
-
Apalsch AM, Green M, Ledesma-Medina J, et al. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20:394.
-
(1995)
Clin Infect Dis
, vol.20
, pp. 394
-
-
Apalsch, A.M.1
Green, M.2
Ledesma-Medina, J.3
-
10
-
-
0028123017
-
Influenza B virus infection in pediatric solid organ transplant recipients
-
Mauch TJ, Bratton S, Myers T, et al. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics 1994; 94 (2 Pt 1):225.
-
(1994)
Pediatrics
, vol.94
, Issue.2 PART 1
, pp. 225
-
-
Mauch, T.J.1
Bratton, S.2
Myers, T.3
-
11
-
-
0028823068
-
Influenza A pneumonitis following treatment of acute cardiac allograft rejection with murine monoclonal anti-CD3 antibody (OKT3)
-
Embrey RP, Geist LJ. Influenza A pneumonitis following treatment of acute cardiac allograft rejection with murine monoclonal anti-CD3 antibody (OKT3). Chest 1995; 108:1456.
-
(1995)
Chest
, vol.108
, pp. 1456
-
-
Embrey, R.P.1
Geist, L.J.2
-
12
-
-
72549088697
-
Guidance on novel influenza A/H1N1 in solid organ transplant recipients
-
Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 2010; 10:18.
-
(2010)
Am J Transplant
, vol.10
, pp. 18
-
-
Kumar, D.1
Morris, M.I.2
Kotton, C.N.3
-
16
-
-
77953284889
-
Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients
-
Vilchez R, McCurry K, Dauber J, et al. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 1075; 73:.
-
Transplantation
, vol.1075
, pp. 73
-
-
Vilchez, R.1
McCurry, K.2
Dauber, J.3
-
19
-
-
34247633653
-
Community respiratory virus infections in immunocompromised patients: Hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection
-
Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 2007; 28:222.
-
(2007)
Semin Respir Crit Care Med
, vol.28
, pp. 222
-
-
Kim, Y.J.1
Boeckh, M.2
Englund, J.A.3
-
21
-
-
66149113991
-
Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice
-
Smee DF, Hurst BL, Wong MH, et al. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob Agents Chemother 2009; 53:2120.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 2120
-
-
Smee, D.F.1
Hurst, B.L.2
Wong, M.H.3
-
22
-
-
70349331605
-
Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro
-
Nguyen JT, Hoopes JD, Smee DF, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother 2009; 53:4115.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 4115
-
-
Nguyen, J.T.1
Hoopes, J.D.2
Smee, D.F.3
-
24
-
-
0029558176
-
Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus
-
Mauch TJ, Crouch NA, Freese DK, et al. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 1995; 127:957.
-
(1995)
J Pediatr
, vol.127
, pp. 957
-
-
Mauch, T.J.1
Crouch, N.A.2
Freese, D.K.3
-
25
-
-
39749137475
-
A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings
-
Madan RP, Tan M, Fernandez-Sesma A, et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis 2008; 46:712.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 712
-
-
Madan, R.P.1
Tan, M.2
Fernandez-Sesma, A.3
-
26
-
-
16644381669
-
Guidelines for vaccination of solid organ transplant candidates and recipients
-
Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004; 4 Suppl 10: 160.
-
(2004)
Am J Transplant
, Issue.4 SUPPL. 10
, pp. 160
-
-
-
28
-
-
7244250306
-
Influenza vaccination in orthotopic liver transplant recipients: Absence of post administration ALT elevation
-
Lawal A, Basler C, Branch A, et al. Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant 2004; 4:1805.
-
(2004)
Am J Transplant
, vol.4
, pp. 1805
-
-
Lawal, A.1
Basler, C.2
Branch, A.3
-
29
-
-
77953287470
-
Clinical impact of communityacquired respiratory viruses on bronchiolitis obliterans after lung transplant
-
Kumar D, Erdman D, Keshavjee S, et al. Clinical impact of communityacquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2031; 5:.
-
Am J Transplant
, vol.2031
, pp. 5
-
-
Kumar, D.1
Erdman, D.2
Keshavjee, S.3
-
30
-
-
33749561630
-
Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: Case report and discussion regarding need of routine prophylaxis
-
Blanchard SS, Gerrek M, Siegel C, Czinn SJ. Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr Transplant 2006; 10:826.
-
(2006)
Pediatr Transplant
, vol.10
, pp. 826
-
-
Blanchard, S.S.1
Gerrek, M.2
Siegel, C.3
Czinn, S.J.4
-
31
-
-
0026569757
-
Respiratory syncytial virus infections in pediatric liver transplant recipients
-
Pohl C, Green M, Wald ER, Ledesma-Medina J. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis 1992; 165:166.
-
(1992)
J Infect Dis
, vol.165
, pp. 166
-
-
Pohl, C.1
Green, M.2
Wald, E.R.3
Ledesma-Medina, J.4
-
32
-
-
0029869946
-
Respiratory syncytial virus infections in pediatric renal transplant recipients
-
Miller RB, Chavers BM. Respiratory syncytial virus infections in pediatric renal transplant recipients. Pediatr Nephrol 1996; 10:213.
-
(1996)
Pediatr Nephrol
, vol.10
, pp. 213
-
-
Miller, R.B.1
Chavers, B.M.2
-
33
-
-
34047143155
-
Development of motavizumab, an ultrapotent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
-
Wu H, Pfarr DS, Johnson S, et al. Development of motavizumab, an ultrapotent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol 2007; 368:652.
-
(2007)
J Mol Biol
, vol.368
, pp. 652
-
-
Wu, H.1
Pfarr, D.S.2
Johnson, S.3
-
34
-
-
65549124546
-
Respiratory syncytial virus prophylaxis: A survey of pediatric solid organ transplant centers
-
Michaels MG, Fonseca-Aten M, Green M, et al. Respiratory syncytial virus prophylaxis: a survey of pediatric solid organ transplant centers. Pediatr Transplant 2009; 13:451.
-
(2009)
Pediatr Transplant
, vol.13
, pp. 451
-
-
Michaels, M.G.1
Fonseca-Aten, M.2
Green, M.3
-
35
-
-
85047700111
-
Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model
-
Ottolini MG, Curtis SR, Mathews A, et al. Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model. Bone Marrow Transplant 2002; 29:117.
-
(2002)
Bone Marrow Transplant
, vol.29
, pp. 117
-
-
Ottolini, M.G.1
Curtis, S.R.2
Mathews, A.3
-
36
-
-
4043169059
-
Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection
-
Saez-Llorens X, Moreno MT, Ramilo O, et al. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection. Pediatr Infect Dis J 2004; 23:707.
-
(2004)
Pediatr Infect Dis J
, vol.23
, pp. 707
-
-
Saez-Llorens, X.1
Moreno, M.T.2
Ramilo, O.3
-
37
-
-
77953288058
-
Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients
-
Chavez-Bueno S, Mejias A, Merryman RA, et al. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J 1089; 26:.
-
Pediatr Infect Dis J
, vol.1089
, pp. 26
-
-
Chavez-Bueno, S.1
Mejias, A.2
Merryman, R.A.3
-
38
-
-
72949116397
-
RNA respiratory viruses in solid organ transplant recipients
-
Ison MG, Michaels MG. RNA respiratory viruses in solid organ transplant recipients. Am J Transplant 2009; 9 (S4):S166.
-
(2009)
Am J Transplant
, vol.9
, Issue.S4
-
-
Ison, M.G.1
Michaels, M.G.2
-
39
-
-
0038299439
-
Adenovirus infection in pediatric small bowel transplantation recipients
-
Pinchoff RJ, Kaufman SS, Magid MS, et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 2003; 76:183.
-
(2003)
Transplantation
, vol.76
, pp. 183
-
-
Pinchoff, R.J.1
Kaufman, S.S.2
Magid, M.S.3
-
40
-
-
77953293141
-
Adenovirus pneumonia in lung transplant recipients
-
Ohori NP, Michaels MG, Jaffe R, et al. Adenovirus pneumonia in lung transplant recipients. Hum Pathol 1073; 26:.
-
Hum Pathol
, vol.1073
, pp. 26
-
-
Ohori, N.P.1
Michaels, M.G.2
Jaffe, R.3
-
42
-
-
33748331285
-
Adenoviral infections in pediatric transplant recipients: A hospital-based study
-
de Mezerville MH, Tellier R, Richardson S, et al. Adenoviral infections in pediatric transplant recipients: a hospital-based study. Pediatr Infect Dis J 2006; 25:815.
-
(2006)
Pediatr Infect Dis J
, vol.25
, pp. 815
-
-
De Mezerville, M.H.1
Tellier, R.2
Richardson, S.3
-
43
-
-
65549144329
-
Adenovirus infection and treatment with cidofovir in children after liver transplantation
-
Engelmann G, Heim A, Greil J, et al. Adenovirus infection and treatment with cidofovir in children after liver transplantation. Pediatr Transplant 2009; 13:421.
-
(2009)
Pediatr Transplant
, vol.13
, pp. 421
-
-
Engelmann, G.1
Heim, A.2
Greil, J.3
-
44
-
-
12344281761
-
Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: Activity against adenovirus replication in vitro
-
Hartline CB, Gustin KM, Wan WB, et al. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. J Infect Dis 2005; 191:396.
-
(2005)
J Infect Dis
, vol.191
, pp. 396
-
-
Hartline, C.B.1
Gustin, K.M.2
Wan, W.B.3
-
45
-
-
0035806735
-
Prediction of severe disseminated adenovirus infection by serum PCR
-
Echavarria M, Forman M, van Tol MJ, et al. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 2001; 358:384.
-
(2001)
Lancet
, vol.358
, pp. 384
-
-
Echavarria, M.1
Forman, M.2
Van Tol, M.J.3
-
46
-
-
33644679022
-
A surveillance study of adenovirus infection in adult solid organ transplant recipients
-
Humar A, Kumar D, Mazzulli T, et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant 2005; 5:2555.
-
(2005)
Am J Transplant
, vol.5
, pp. 2555
-
-
Humar, A.1
Kumar, D.2
Mazzulli, T.3
-
47
-
-
33847634017
-
Zoonoses in solid-organ and hematopoietic stem cell transplant recipients
-
Kotton CN. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 2007; 44:857.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 857
-
-
Kotton, C.N.1
-
48
-
-
51849131989
-
Screening of organ and tissue donors for West Nile virus by nucleic acid amplification: A three year experience in Alberta
-
Tilley PA, Fox JD, Lee B, et al. Screening of organ and tissue donors for West Nile virus by nucleic acid amplification: a three year experience in Alberta. Am J Transplant 2008; 8:2119.
-
(2008)
Am J Transplant
, vol.8
, pp. 2119
-
-
Tilley, P.A.1
Fox, J.D.2
Lee, B.3
-
49
-
-
33646875293
-
Transmission of lymphocytic choriomeningitis virus by organ transplantation
-
Fischer SA, Graham MB, Kuehnert MJ, et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006; 354:2235.
-
(2006)
N Engl J Med
, vol.354
, pp. 2235
-
-
Fischer, S.A.1
Graham, M.B.2
Kuehnert, M.J.3
-
50
-
-
0017743375
-
Lymphocytic choriomeningitis in laboratory personnel exposed to hamsters inadvertently infected with LCM virus
-
Biggar RJ, Schmidt TJ, Woodall JP. Lymphocytic choriomeningitis in laboratory personnel exposed to hamsters inadvertently infected with LCM virus. J Am Vet Med Assoc 1977; 171:829.
-
(1977)
J Am Vet Med Assoc
, vol.171
, pp. 829
-
-
Biggar, R.J.1
Schmidt, T.J.2
Woodall, J.P.3
-
51
-
-
20144376356
-
Transmission of rabies virus from an organ donor to four transplant recipients
-
Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352:1103.
-
(2005)
N Engl J Med
, vol.352
, pp. 1103
-
-
Srinivasan, A.1
Burton, E.C.2
Kuehnert, M.J.3
-
52
-
-
0038526363
-
Transmission of West Nile virus from an organ donor to four transplant recipients
-
Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196.
-
(2003)
N Engl J Med
, vol.348
, pp. 2196
-
-
Iwamoto, M.1
Jernigan, D.B.2
Guasch, A.3
-
53
-
-
70749132777
-
West Nile virus transmission via organ transplantation and blood transfusion: Louisiana, 2008
-
West Nile virus transmission via organ transplantation and blood transfusion: Louisiana, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:1263.
-
(2009)
MMWR Morb Mortal Wkly Rep
, vol.58
, pp. 1263
-
-
-
54
-
-
77950319535
-
Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients
-
Levi ME, Quan D, Ho JT, et al. Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant 2009; 23:437-446.
-
(2009)
Clin Transplant
, vol.23
, pp. 437-446
-
-
Levi, M.E.1
Quan, D.2
Ho, J.T.3
-
55
-
-
7244234467
-
A seroprevalence study of west Nile virus infection in solid organ transplant recipients
-
Kumar D, Drebot MA, Wong SJ, et al. A seroprevalence study of west Nile virus infection in solid organ transplant recipients. Am J Transplant 2004; 4:1883.
-
(2004)
Am J Transplant
, vol.4
, pp. 1883
-
-
Kumar, D.1
Drebot, M.A.2
Wong, S.J.3
-
56
-
-
77953285954
-
Seroprevalence of West Nile virus infection in solid organ transplant recipients
-
Freifeld AG, Meza J, Schweitzer B, et al. Seroprevalence of West Nile virus infection in solid organ transplant recipients. Transpl Infect Dis 2009.
-
(2009)
Transpl Infect Dis
-
-
Freifeld, A.G.1
Meza, J.2
Schweitzer, B.3
-
57
-
-
33846572432
-
Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation
-
Li L, Chaudhuri A, Weintraub LA, et al. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant 2007; 11:187.
-
(2007)
Pediatr Transplant
, vol.11
, pp. 187
-
-
Li, L.1
Chaudhuri, A.2
Weintraub, L.A.3
-
58
-
-
0033611067
-
Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients
-
Humar A, Gillingham KJ, Payne WD, et al. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 1999; 68:1879.
-
(1999)
Transplantation
, vol.68
, pp. 1879
-
-
Humar, A.1
Gillingham, K.J.2
Payne, W.D.3
-
59
-
-
0036723794
-
Infections and solid organ transplant rejection: A causeand- effect relationship?
-
Cainelli F, Vento S. Infections and solid organ transplant rejection: a causeand- effect relationship? Lancet Infect Dis 2002; 2:539.
-
(2002)
Lancet Infect Dis
, vol.2
, pp. 539
-
-
Cainelli, F.1
Vento, S.2
-
60
-
-
0031956205
-
Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients
-
Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998; 26:753.
-
(1998)
Clin Infect Dis
, vol.26
, pp. 753
-
-
Husni, R.N.1
Gordon, S.M.2
Longworth, D.L.3
-
61
-
-
27744472100
-
A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: Effects of virus-induced immunomodulation on disease progression
-
Qureshi MH, Garvy BA, Pomeroy C, et al. A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression. Virus Res 2005; 114 (1-2):35.
-
(2005)
Virus Res
, vol.114
, Issue.1-2
, pp. 35
-
-
Qureshi, M.H.1
Garvy, B.A.2
Pomeroy, C.3
-
62
-
-
0030792873
-
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients
-
Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland
-
George MJ, Snydman DR, Werner BG, et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med 1997; 103:106.
-
(1997)
Am J Med
, vol.103
, pp. 106
-
-
George, M.J.1
Snydman, D.R.2
Werner, B.G.3
-
63
-
-
34547829434
-
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients
-
Asberg A, Humar A, Rollag H, et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2007; 7:2106.
-
(2007)
Am J Transplant
, vol.7
, pp. 2106
-
-
Asberg, A.1
Humar, A.2
Rollag, H.3
-
64
-
-
39349116597
-
Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients
-
Len O, Gavalda J, Aguado JM, et al. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients. Clin Infect Dis 2008; 46:20.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 20
-
-
Len, O.1
Gavalda, J.2
Aguado, J.M.3
-
65
-
-
65249181619
-
Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients
-
Asberg A, Humar A, Jardine AG, et al. Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant 2009; 9:1205.
-
(2009)
Am J Transplant
, vol.9
, pp. 1205
-
-
Asberg, A.1
Humar, A.2
Jardine, A.G.3
-
66
-
-
2442648883
-
Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients
-
Clark BS, Chang IF, Karpen SJ, et al. Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients. Transplantation 2004; 77:1480.
-
(2004)
Transplantation
, vol.77
, pp. 1480
-
-
Clark, B.S.1
Chang, I.F.2
Karpen, S.J.3
-
67
-
-
60749110137
-
Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients
-
Vaudry W, Ettenger R, Jara P, et al. Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients. Am J Transplant 2009; 9:636.
-
(2009)
Am J Transplant
, vol.9
, pp. 636
-
-
Vaudry, W.1
Ettenger, R.2
Jara, P.3
-
68
-
-
1942469969
-
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
-
Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004; 4:611.
-
(2004)
Am J Transplant
, vol.4
, pp. 611
-
-
Paya, C.1
Humar, A.2
Dominguez, E.3
-
69
-
-
40749092437
-
Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation
-
Chmiel C, Speich R, Hofer M, et al. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis 2008; 46:831.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 831
-
-
Chmiel, C.1
Speich, R.2
Hofer, M.3
-
70
-
-
40749108069
-
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation
-
Arthurs SK, Eid AJ, Pedersen RA, et al. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 2008; 46:840.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 840
-
-
Arthurs, S.K.1
Eid, A.J.2
Pedersen, R.A.3
-
71
-
-
65849405940
-
Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: An evidence-based reassessment of safety and efficacy
-
Kalil AC, Freifeld AG, Lyden ER, Stoner JA. Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy. PLoS One 2009; 4:e5512.
-
(2009)
PLoS One
, vol.4
-
-
Kalil, A.C.1
Freifeld, A.G.2
Lyden, E.R.3
Stoner, J.A.4
-
72
-
-
34547645045
-
Incidence and clinical features of ganciclovirresistant cytomegalovirus disease in heart transplant recipients
-
Li F, Kenyon KW, Kirby KA, et al. Incidence and clinical features of ganciclovirresistant cytomegalovirus disease in heart transplant recipients. Clin Infect Dis 2007; 45:439.
-
(2007)
Clin Infect Dis
, vol.45
, pp. 439
-
-
Li, F.1
Kenyon, K.W.2
Kirby, K.A.3
-
73
-
-
39449093095
-
Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus- seropositive donor allografts
-
Singh N, Wannstedt C, Keyes L, et al. Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts. Liver Transpl 2008; 14:240.
-
(2008)
Liver Transpl
, vol.14
, pp. 240
-
-
Singh, N.1
Wannstedt, C.2
Keyes, L.3
-
74
-
-
67649600984
-
A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients
-
Madan RP, Campbell AL, Shust GF, et al. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients. Transplantation 2009; 87:1318.
-
(2009)
Transplantation
, vol.87
, pp. 1318
-
-
Madan, R.P.1
Campbell, A.L.2
Shust, G.F.3
-
75
-
-
12344298316
-
Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: Impact on viral load and late-onset cytomegalovirus disease
-
Singh N, Wannstedt C, Keyes L, et al. Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease. Transplantation 2005; 79:85.
-
(2005)
Transplantation
, vol.79
, pp. 85
-
-
Singh, N.1
Wannstedt, C.2
Keyes, L.3
-
76
-
-
33747460001
-
Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients
-
Diaz-Pedroche C, Lumbreras C, San Juan R, et al. Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients. Transplantation 2006; 82: 30.
-
(2006)
Transplantation
, vol.82
, pp. 30
-
-
Diaz-Pedroche, C.1
Lumbreras, C.2
San Juan, R.3
-
77
-
-
0030901675
-
Cytomegalovirus disease occurring before engraftment in marrow transplant recipients
-
Limaye AP, Bowden RA, Myerson D, Boeckh M. Cytomegalovirus disease occurring before engraftment in marrow transplant recipients. Clin Infect Dis 1997; 24:830.
-
(1997)
Clin Infect Dis
, vol.24
, pp. 830
-
-
Limaye, A.P.1
Bowden, R.A.2
Myerson, D.3
Boeckh, M.4
-
78
-
-
30844432417
-
Lymphoproliferative disorders after paediatric heart transplantation: A multiinstitutional study
-
Webber SA, Naftel DC, Fricker FJ, et al. Lymphoproliferative disorders after paediatric heart transplantation: a multiinstitutional study. Lancet 2006; 367:233.
-
(2006)
Lancet
, vol.367
, pp. 233
-
-
Webber, S.A.1
Naftel, D.C.2
Fricker, F.J.3
-
79
-
-
38149027702
-
Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children
-
Bingler MA, Feingold B, Miller SA, et al. Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children. Am J Transplant 2008; 8:442.
-
(2008)
Am J Transplant
, vol.8
, pp. 442
-
-
Bingler, M.A.1
Feingold, B.2
Miller, S.A.3
-
80
-
-
0035008468
-
The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and posttransplant lymphoproliferative disease following solid organ transplantation
-
Green M, Reyes J, Webber S, Rowe D. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and posttransplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis 2001; 3:97.
-
(2001)
Transpl Infect Dis
, vol.3
, pp. 97
-
-
Green, M.1
Reyes, J.2
Webber, S.3
Rowe, D.4
-
81
-
-
33745785855
-
CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients
-
Green M, Michaels MG, Katz BZ, et al. CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Am J Transplant 1906; 6:.
-
(1906)
Am J Transplant
, pp. 6
-
-
Green, M.1
Michaels, M.G.2
Katz, B.Z.3
-
82
-
-
0035187510
-
The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: A preliminary experience
-
Kogan-Liberman D, Burroughs M, Emre S, et al. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr 2001; 33:445.
-
(2001)
J Pediatr Gastroenterol Nutr
, vol.33
, pp. 445
-
-
Kogan-Liberman, D.1
Burroughs, M.2
Emre, S.3
-
83
-
-
27844591787
-
Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients
-
Lee TC, Savoldo B, Rooney CM, et al. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 2005; 5:2222.
-
(2005)
Am J Transplant
, vol.5
, pp. 2222
-
-
Lee, T.C.1
Savoldo, B.2
Rooney, C.M.3
-
84
-
-
49049109688
-
Effect of Epstein-Barr virus sequence variation on performance of the Roche real-time LightCycler PCR assay
-
Feng T, Ye F, Wu J, et al. Effect of Epstein-Barr virus sequence variation on performance of the Roche real-time LightCycler PCR assay. J Clin Microbiol 2008; 46:2463.
-
(2008)
J Clin Microbiol
, vol.46
, pp. 2463
-
-
Feng, T.1
Ye, F.2
Wu, J.3
-
85
-
-
42149185667
-
EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial
-
Tsai DE, Douglas L, Andreadis C, et al. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial. Am J Transplant 2008; 8:1016.
-
(2008)
Am J Transplant
, vol.8
, pp. 1016
-
-
Tsai, D.E.1
Douglas, L.2
Andreadis, C.3
-
87
-
-
0031042113
-
Posttransplant lymphoproliferative disorders: Summary of Society for Hematopathology Workshop
-
Harris NL, Ferry JA,SwerdlowSH.Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol 1997; 14:8.
-
(1997)
Semin Diagn Pathol
, vol.14
, pp. 8
-
-
Harris, N.L.1
Ferry, J.A.2
Swerdlow, S.H.3
-
89
-
-
27244449778
-
Low-dose chemotherapy for Epstein- Barr virus-positive posttransplantation lymphoproliferative disease in children after solid organ transplantation
-
Gross TG, Bucuvalas JC, Park JR, et al. Low-dose chemotherapy for Epstein- Barr virus-positive posttransplantation lymphoproliferative disease in children after solid organ transplantation. J Clin Oncol 2005; 23:6481.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6481
-
-
Gross, T.G.1
Bucuvalas, J.C.2
Park, J.R.3
-
90
-
-
0032170108
-
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
-
Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92:1549.
-
(1998)
Blood
, vol.92
, pp. 1549
-
-
Rooney, C.M.1
Smith, C.A.2
Ng, C.Y.3
-
91
-
-
77953288691
-
Generation of autologous Epstein-Barr virusspecific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients
-
Savoldo B, Goss J, Liu Z, et al. Generation of autologous Epstein-Barr virusspecific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. Transplantation 1078; 72:.
-
Transplantation
, vol.1078
, pp. 72
-
-
Savoldo, B.1
Goss, J.2
Liu, Z.3
-
92
-
-
0036530234
-
Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication
-
Comoli P, Labirio M, Basso S, et al. Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. Blood 2002; 99:2592.
-
(2002)
Blood
, vol.99
, pp. 2592
-
-
Comoli, P.1
Labirio, M.2
Basso, S.3
-
93
-
-
74049116602
-
Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease
-
Brewin J, Mancao C, Straathof K, et al. Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. Blood 2009; 114:4792.
-
(2009)
Blood
, vol.114
, pp. 4792
-
-
Brewin, J.1
Mancao, C.2
Straathof, K.3
-
94
-
-
73449085640
-
Generation of Epstein-Barr virusspecific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)
-
De Angelis B, Dotti G, Quintarelli C, et al. Generation of Epstein-Barr virusspecific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506). Blood 2009; 114:4784.
-
(2009)
Blood
, vol.114
, pp. 4784
-
-
De Angelis, B.1
Dotti, G.2
Quintarelli, C.3
-
95
-
-
0035401232
-
Management of Epstein-Barr virus-induced posttransplant lymphoproliferative disease in recipients of solid organ transplantation
-
Green M. Management of Epstein-Barr virus-induced posttransplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 2001; 1:103.
-
(2001)
Am J Transplant
, vol.1
, pp. 103
-
-
Green, M.1
|